Skip to content

Semi-Recumbent Vibration Therapy in Older Adults

Semi-Recumbent Vibration Therapy in Older Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02533063
Enrollment
32
Registered
2015-08-26
Start date
2015-11-30
Completion date
2017-02-15
Last updated
2019-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Sarcopenia

Brief summary

This proposed prospective study will evaluate whether a novel exercise approach, seated vibration therapy, can improve function in the target population of older adults. Therefore, the primary aim of this pilot is to examine the effect of vibration therapy on muscle function (balance, muscle power and strength) and muscle mass.

Detailed description

There are four study visits; screening/baseline followed by eight weeks of training three times a week, visit 1 at eight weeks followed by 4 weeks of washout, Visit 2 at 12 weeks followed by eight weeks of training three times a week, and a final Visit 3 at 20 weeks. At the screening visit, volunteers will be asked to perform tests included in the short physical performance battery (SPPB) (gait speed, chair rise, balance). If the participants score is ≤ 9 or ≤ 2 in any of the three tests included in the SPPB they will be eligible for the intervention phase. At the baseline visit several questionnaires will be obtained and participants then will proceed with muscle function tests (SPPB, jumping mechanography, grip strength, timed-up-and-go test). Participants will then be randomized into one of two groups. The first group will receive vibration + loading treatment for the first 8 weeks, the second group will receive sham treatment (loading only). After 8 weeks both groups will go through a 4 week wash-out period and then crossover will occur. The first group will now receive sham treatment (loading only) while the second group will receive vibration + loading treatment. The participants will train for 10 minutes, 3 times a week, during the active 16 total weeks.

Interventions

DEVICEVibeTech One

Vibration Training The VibeTech One Rehab Chair allows vibration exercise while seated. A force is applied on a footplate that simulates the weight of standing or partial bodyweight. The participants will train for 10 minutes 3 days per week. In the loading + vibration group (intervention group) vibratory acceleration will be 30Hz and the applied load will be 50% of body weight up to a device maximum applied load of 100 lbs. Vibration intensity will initially be set to 0.2 g and will increase by 0.2 g every other week, as tolerated by the subject, and max out at 1.0 g.

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Men and women age ≥ 70 years 2. Able and willing to sign informed consent 3. Able to stand without assistance 4. Able and willing to train for 10 minutes, 3 times per week 5. Total SPPB score of ≤ 9 or ≤ 2 in any of the three tests included in the SPPB

Exclusion criteria

1. Cognitive impairment to the degree that it limits the ability of signing informed consent 2. Unable to sit upright for 10 minutes 3. History of injury or surgery within the prior six months which limits the ability to ambulate 4. Major illness that might cause missed training sessions or visits.

Design outcomes

Primary

MeasureTime frameDescription
Weight Corrected Jump Power Based on Participant's Jump on the Jump Force PlateThis was collected 4 times: Baseline, after 8 week loading/loading+ vibration training, after 4 week washout, after 8 week crossover training.The primary aim of this pilot is to examine the effect of vibration therapy on muscle function. Weight corrected jump power will be the main outcome variable. Countermovement jumps are performed on a Leonardo force plate (Novotec Medical, Pforzheim, Germany) following standard procedures. Jumping mechanography uses maximal countermovement jumps to quantitatively measure muscle strength in the legs. Participants will be asked to perform three countermovement jumps. Participants are asked to try to jump as high as possible using both legs. Three jumps are performed; the jump with the highest jump height is used for analysis.

Secondary

MeasureTime frameDescription
Grip StrengthMeasured at Baseline, after Intervention 1, after Washout, and after Intervention 2.Grip Strengthwas acquired using a JAMAR hand dynamometer in the routine clinical manner. Measurements were recorded using participants' non-dominant hand and repeated 3 times to determine maximum grip strength.
Gait SpeedMeasured at Baseline, after Intervention 1, after Washout, and after Intervention 2.Gait speed will be measured by instructing participants to walk four meters at their normal pace; they are timed with a stopwatch. This test will be repeated twice. The walk performed in the least time will be utilized for scoring purposes.
SwayMeasured at Baseline, after Intervention 1, after Washout, and after Intervention 2.Sway is assessed by having the participants stand with feet being placed side by side for ten seconds. Participants will be wearing MobilityLabTM (APDM, Portland, OR) sensors on their chest, lower back, wrists and feet during these tests to collect computerized sway data.
Timed-Up-and-Go (TUG)Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.The Timed-Up-and-Go (TUG) test will be performed twice; participants will be seated in an armless chair, upon instruction, they will be asked to stand, which starts the timing, they will walk 3 meters past a mark on the floor at their normal pace, turn around and return to a full seated position, at which time the test will end.
Bioelectrical Impedance Spectroscopy (BIS)Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.An ImpediMed SFB7 device (Eight Mile Plains, Queensland, Australia) will be used to obtain these measurements. Participants will be positioned supine for a minimum of 10 minutes prior to acquisition; adequate separation of their legs will be obtained to allow for accurate BIS measurement. Measurements will be obtained by placing four EKG-like electrodes on the skin of the participant's hand, feet and knee. Wires will be attached from the BIS device to these skin electrodes. Painless electric waves will be sent through the tissues as noted above. Each measurement lasts only a few seconds. This method will generate measurements of lean mass.
Short Physical Performance Battery (SPPB)Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.The short physical performance battery (SPPB) consists of gait speed as determined by a four-meter walk, timed repeated chair rise and standing balance. Gait speed will be measured by instructing participants to walk four meters at their normal pace; timed with a stopwatch and is repeated twice. The walk performed in the least time will be utilized for SPPB scoring purposes. The timed repeated chair rise has participants stand up from a chair five times without the use of their arms, if possible. Time to complete five stands is measured. Standing balance is assessed by having the participants stand in three positions of increasing difficulty for 10 seconds each. Standardized instructions will be given to all participants and the test performed twice. The SPPB will be conducted and scored in standard manner, score 0-12, with lower scores indicating mobility limitations. Participants will be wearing MobilityLabTM sensors to collect computerized data for these tests.

Other

MeasureTime frameDescription
Adherence and Factors That Influence Adherence-Exercise EnjoymentThis was collected at the end of each 8 week intervention period.Exercise enjoyment for each intervention was assessed using the validated questionnaire, 5-point Likert scale. Response options include strongly agree, agree, neutral, disagree, strongly agree.
Adherence and Factors That Influence Adherence-PainThis was collected before and after training during each of the 8 week interventions.Self-reported pre- and post-training pain during the vibration intervention and control sessions were calculated as the mean for each participant using a validated questionnaire, Comprehensive Pain Assessment Form with scale from 0-10, 0 being no pain and 10 being severe pain.

Countries

United States

Participant flow

Participants by arm

ArmCount
Loading + Vibration, Then Loading Only
In Loading + Vibration intervention phase, subjects will be seated in the VibeTech One Rehab Chair, which allows vibration exercise while seated. A force is applied on a footplate that simulates the weight of standing or partial bodyweight. The participants will train for 10 minutes 3 days per week. The vibratory acceleration will be 30Hz and the applied load will be 50% of body weight up to a device maximum applied load of 100 lbs. Vibration intensity will initially be set to 0.2 g and will increase by 0.2 g every other week, as tolerated by the subject, and max of 1.0 g. In Loading Only control phase participants will be seated in the vibration device (VibeTech One) and will experience loading of their leg muscles through the device with no vibration.
16
Loading Only, Then Loading + Vibration
In Loading + Vibration intervention phase, subjects will be seated in the VibeTech One Rehab Chair, which allows vibration exercise while seated. A force is applied on a footplate that simulates the weight of standing or partial bodyweight. The participants will train for 10 minutes 3 days per week. The vibratory acceleration will be 30Hz and the applied load will be 50% of body weight up to a device maximum applied load of 100 lbs. Vibration intensity will initially be set to 0.2 g and will increase by 0.2 g every other week, as tolerated by the subject, and max of 1.0 g. In Loading Only control phase participants will be seated in the vibration device (VibeTech One) and will experience loading of their leg muscles through the device with no vibration.
16
Total32

Baseline characteristics

CharacteristicLoading + Vibration, Then Loading OnlyLoading Only, Then Loading + VibrationTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
16 Participants16 Participants32 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous87.9 years86.9 years87.4 years
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
16 Participants16 Participants32 Participants
Region of Enrollment
United States
16 Participants16 Participants32 Participants
Sex: Female, Male
Female
10 Participants13 Participants23 Participants
Sex: Female, Male
Male
6 Participants3 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 320 / 32
other
Total, other adverse events
14 / 323 / 32
serious
Total, serious adverse events
4 / 322 / 32

Outcome results

Primary

Weight Corrected Jump Power Based on Participant's Jump on the Jump Force Plate

The primary aim of this pilot is to examine the effect of vibration therapy on muscle function. Weight corrected jump power will be the main outcome variable. Countermovement jumps are performed on a Leonardo force plate (Novotec Medical, Pforzheim, Germany) following standard procedures. Jumping mechanography uses maximal countermovement jumps to quantitatively measure muscle strength in the legs. Participants will be asked to perform three countermovement jumps. Participants are asked to try to jump as high as possible using both legs. Three jumps are performed; the jump with the highest jump height is used for analysis.

Time frame: This was collected 4 times: Baseline, after 8 week loading/loading+ vibration training, after 4 week washout, after 8 week crossover training.

Population: In this frail population a number of individuals were unable to perform satisfactory jumps to collect valid data with the current software.

ArmMeasureGroupValue (MEAN)Dispersion
Loading + VibrationWeight Corrected Jump Power Based on Participant's Jump on the Jump Force PlatePre Intervention10.53 W/kgStandard Deviation 5.66
Loading + VibrationWeight Corrected Jump Power Based on Participant's Jump on the Jump Force PlatePost Intervention11.10 W/kgStandard Deviation 7.03
Loading OnlyWeight Corrected Jump Power Based on Participant's Jump on the Jump Force PlatePre Intervention10.28 W/kgStandard Deviation 7.11
Loading OnlyWeight Corrected Jump Power Based on Participant's Jump on the Jump Force PlatePost Intervention8.98 W/kgStandard Deviation 5.33
p-value: 0.217ANOVA
Secondary

Bioelectrical Impedance Spectroscopy (BIS)

An ImpediMed SFB7 device (Eight Mile Plains, Queensland, Australia) will be used to obtain these measurements. Participants will be positioned supine for a minimum of 10 minutes prior to acquisition; adequate separation of their legs will be obtained to allow for accurate BIS measurement. Measurements will be obtained by placing four EKG-like electrodes on the skin of the participant's hand, feet and knee. Wires will be attached from the BIS device to these skin electrodes. Painless electric waves will be sent through the tissues as noted above. Each measurement lasts only a few seconds. This method will generate measurements of lean mass.

Time frame: Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.

ArmMeasureGroupValue (MEAN)Dispersion
Loading + VibrationBioelectrical Impedance Spectroscopy (BIS)Pre Intervention41.75 Mass (kg)Standard Deviation 7.36
Loading + VibrationBioelectrical Impedance Spectroscopy (BIS)Post Intervention42.19 Mass (kg)Standard Deviation 8.23
Loading OnlyBioelectrical Impedance Spectroscopy (BIS)Pre Intervention41.86 Mass (kg)Standard Deviation 6.34
Loading OnlyBioelectrical Impedance Spectroscopy (BIS)Post Intervention41.71 Mass (kg)Standard Deviation 6.71
p-value: 0.483ANOVA
Secondary

Gait Speed

Gait speed will be measured by instructing participants to walk four meters at their normal pace; they are timed with a stopwatch. This test will be repeated twice. The walk performed in the least time will be utilized for scoring purposes.

Time frame: Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.

ArmMeasureGroupValue (MEAN)Dispersion
Loading + VibrationGait SpeedPre Intervention0.6 Speed (m/sec)Standard Deviation 0.2
Loading + VibrationGait SpeedPost Intervention0.7 Speed (m/sec)Standard Deviation 0.3
Loading OnlyGait SpeedPre Intervention0.7 Speed (m/sec)Standard Deviation 0.2
Loading OnlyGait SpeedPost Intervention0.7 Speed (m/sec)Standard Deviation 0.2
p-value: 0.151ANOVA
Secondary

Grip Strength

Grip Strengthwas acquired using a JAMAR hand dynamometer in the routine clinical manner. Measurements were recorded using participants' non-dominant hand and repeated 3 times to determine maximum grip strength.

Time frame: Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.

ArmMeasureGroupValue (MEAN)Dispersion
Loading + VibrationGrip StrengthPre Intervention13.8 Force (kg)Standard Deviation 6
Loading + VibrationGrip StrengthPost Intervention13.3 Force (kg)Standard Deviation 6.4
Loading OnlyGrip StrengthPre Intervention12.9 Force (kg)Standard Deviation 5.6
Loading OnlyGrip StrengthPost Intervention14.1 Force (kg)Standard Deviation 5
p-value: 0.501ANOVA
Secondary

Short Physical Performance Battery (SPPB)

The short physical performance battery (SPPB) consists of gait speed as determined by a four-meter walk, timed repeated chair rise and standing balance. Gait speed will be measured by instructing participants to walk four meters at their normal pace; timed with a stopwatch and is repeated twice. The walk performed in the least time will be utilized for SPPB scoring purposes. The timed repeated chair rise has participants stand up from a chair five times without the use of their arms, if possible. Time to complete five stands is measured. Standing balance is assessed by having the participants stand in three positions of increasing difficulty for 10 seconds each. Standardized instructions will be given to all participants and the test performed twice. The SPPB will be conducted and scored in standard manner, score 0-12, with lower scores indicating mobility limitations. Participants will be wearing MobilityLabTM sensors to collect computerized data for these tests.

Time frame: Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.

Population: Not all participants completed the SPPB test.

ArmMeasureGroupValue (MEAN)Dispersion
Loading + VibrationShort Physical Performance Battery (SPPB)Pre Intervention6.8 score on a scaleStandard Deviation 2.8
Loading + VibrationShort Physical Performance Battery (SPPB)Post Intervention6.8 score on a scaleStandard Deviation 2.8
Loading OnlyShort Physical Performance Battery (SPPB)Pre Intervention7.0 score on a scaleStandard Deviation 2.8
Loading OnlyShort Physical Performance Battery (SPPB)Post Intervention7.0 score on a scaleStandard Deviation 3
p-value: 0.678ANOVA
Secondary

Sway

Sway is assessed by having the participants stand with feet being placed side by side for ten seconds. Participants will be wearing MobilityLabTM (APDM, Portland, OR) sensors on their chest, lower back, wrists and feet during these tests to collect computerized sway data.

Time frame: Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.

Population: Not all participants could complete the balance exercise and provide valid data for this measure.

ArmMeasureGroupValue (MEAN)Dispersion
Loading + VibrationSwayPre Intervention9.2 Area (cm square)Standard Deviation 15.8
Loading + VibrationSwayPost Intervention5.8 Area (cm square)Standard Deviation 3.4
Loading OnlySwayPre Intervention4.8 Area (cm square)Standard Deviation 6.3
Loading OnlySwayPost Intervention4.7 Area (cm square)Standard Deviation 4.2
p-value: 0.45ANOVA
Secondary

Timed-Up-and-Go (TUG)

The Timed-Up-and-Go (TUG) test will be performed twice; participants will be seated in an armless chair, upon instruction, they will be asked to stand, which starts the timing, they will walk 3 meters past a mark on the floor at their normal pace, turn around and return to a full seated position, at which time the test will end.

Time frame: Measured at Baseline, after Intervention 1, after Washout, and after Intervention 2.

Population: Not all participants completed the TUG testing.

ArmMeasureGroupValue (MEAN)Dispersion
Loading + VibrationTimed-Up-and-Go (TUG)Pre Intervention18.6 Time (seconds)Standard Deviation 7.8
Loading + VibrationTimed-Up-and-Go (TUG)Post Intervention20.5 Time (seconds)Standard Deviation 10.1
Loading OnlyTimed-Up-and-Go (TUG)Pre Intervention18.4 Time (seconds)Standard Deviation 6.8
Loading OnlyTimed-Up-and-Go (TUG)Post Intervention19.3 Time (seconds)Standard Deviation 8.4
p-value: 0.06ANOVA
Other Pre-specified

Adherence and Factors That Influence Adherence-Exercise Enjoyment

Exercise enjoyment for each intervention was assessed using the validated questionnaire, 5-point Likert scale. Response options include strongly agree, agree, neutral, disagree, strongly agree.

Time frame: This was collected at the end of each 8 week intervention period.

ArmMeasureGroupValue (NUMBER)
Loading + VibrationAdherence and Factors That Influence Adherence-Exercise EnjoymentAgree to Neutral40 percentage of participants
Loading + VibrationAdherence and Factors That Influence Adherence-Exercise EnjoymentDisagree0 percentage of participants
Loading + VibrationAdherence and Factors That Influence Adherence-Exercise EnjoymentNeutral48 percentage of participants
Loading + VibrationAdherence and Factors That Influence Adherence-Exercise EnjoymentStrongly disagree0 percentage of participants
Loading + VibrationAdherence and Factors That Influence Adherence-Exercise EnjoymentStrongly agree12 percentage of participants
Loading OnlyAdherence and Factors That Influence Adherence-Exercise EnjoymentStrongly disagree0 percentage of participants
Loading OnlyAdherence and Factors That Influence Adherence-Exercise EnjoymentStrongly agree0 percentage of participants
Loading OnlyAdherence and Factors That Influence Adherence-Exercise EnjoymentAgree to Neutral33 percentage of participants
Loading OnlyAdherence and Factors That Influence Adherence-Exercise EnjoymentNeutral67 percentage of participants
Loading OnlyAdherence and Factors That Influence Adherence-Exercise EnjoymentDisagree0 percentage of participants
Other Pre-specified

Adherence and Factors That Influence Adherence-Pain

Self-reported pre- and post-training pain during the vibration intervention and control sessions were calculated as the mean for each participant using a validated questionnaire, Comprehensive Pain Assessment Form with scale from 0-10, 0 being no pain and 10 being severe pain.

Time frame: This was collected before and after training during each of the 8 week interventions.

ArmMeasureGroupValue (NUMBER)
Loading + VibrationAdherence and Factors That Influence Adherence-PainPre-training 0-384 percentage of participants
Loading + VibrationAdherence and Factors That Influence Adherence-PainPre-training 4-616 percentage of participants
Loading + VibrationAdherence and Factors That Influence Adherence-PainPre-training 7-100 percentage of participants
Loading + VibrationAdherence and Factors That Influence Adherence-PainPost-training 0-388 percentage of participants
Loading + VibrationAdherence and Factors That Influence Adherence-PainPost-training 4-612 percentage of participants
Loading + VibrationAdherence and Factors That Influence Adherence-PainPost-training 7-100 percentage of participants
Loading OnlyAdherence and Factors That Influence Adherence-PainPost-training 4-64 percentage of participants
Loading OnlyAdherence and Factors That Influence Adherence-PainPre-training 0-396 percentage of participants
Loading OnlyAdherence and Factors That Influence Adherence-PainPost-training 0-396 percentage of participants
Loading OnlyAdherence and Factors That Influence Adherence-PainPre-training 4-64 percentage of participants
Loading OnlyAdherence and Factors That Influence Adherence-PainPost-training 7-100 percentage of participants
Loading OnlyAdherence and Factors That Influence Adherence-PainPre-training 7-100 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026